| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |